NIFTY 50▲25,790.95
375.15 (1.48%)
SENSEX▲84,544.31
1359.51 (1.63%)
NIFTY BANK▲53,793.20
755.60 (1.42%)
TATA MOTORS▲970.85
3.85 (0.40%)
SUZLON ENERGY▲83.45
2.48 (3.06%)
INDIAN RAILWAY FINANCE CORP▲161.43
6.18 (3.98%)
TATA STEEL▲152.02
2.48 (1.66%)
TATA POWER▲444.15
4.55 (1.04%)
RAIL VIKAS NIGAM▲544.25
34.05 (6.67%)
RELIANCE INDUSTRIES▲2,971.85
32.50 (1.11%)
VODAFONE IDEA▲10.47
0.09 (0.87%)
INDIAN RENEWABLE ENERGY▲232.37
2.36 (1.03%)
ZOMATO▲290.50
11.65 (4.18%)
ADANI POWER▲665.15
15.55 (2.39%)
YES BANK▲23.00
0.05 (0.22%)
RELIANCE POWER▲36.34
1.73 (5.00%)
NHPC▲94.65
2.22 (2.40%)
STATE BANK OF INDIA▼781.70
-8.25 (-1.04%)
HDFC BANK▲1,741.20
32.70 (1.91%)
JIO FIN SERVICES LTD▲353.90
7.25 (2.09%)
OLA ELECTRIC MOBILITY LTD▼110.99
-0.68 (-0.61%)
ADANI PORT & SEZ▲1,438.70
30.50 (2.17%)
BHARAT ELECTRONICS▲277.35
4.65 (1.71%)
GTL INFRA▲2.38
0.01 (0.42%)
INDIAN OIL CORP▲167.05
2.01 (1.22%)
MRF▼1,35,934.40
-413.20 (-0.30%)
INDIAN RAILWAY TOURISM CORP▲894.25
10.60 (1.20%)
RATTANINDIA POWER▼14.46
-0.49 (-3.28%)
Shilpa Medicare Share Price
SHILPAMED
₹866.65+₹18.60 (2.19%) TodayLast updated on 20 Sep, 2024 | 15:52 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹853.40 | Close₹848.05 |
Circuit range₹1,039.95 - ₹693.35 | Day range₹846.55 - ₹869.40 | Year range₹296.80 - ₹959.50 |
Volume2,24,041 | Avg. traded₹857.98 | Revenue (12m)₹1,184 Crs |
Shilpa MedicareShilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.
Shilpa Medicare Key indicators
52 week high₹959.50 | 52 week low₹296.80 | P/E ratio173.5 |
P/B ratio3.8 | ROE1.26% | ROCE2.36% |
Dividend yield-- | Debt/Equity ratio0.07 | EPS3.1 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin37.25% | Net profit margin8.7% |
ROE1.26% | ROA1.09% |
ROCE2.36% |
Learn more
Shilpa Medicare Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Sep 20 2024 | ₹853.40 | ₹866.65 | |
Thu, Sep 19 2024 | ₹912.70 | ₹848.05 | -5.97% |
Wed, Sep 18 2024 | ₹883.00 | ₹901.90 | |
Tue, Sep 17 2024 | ₹895.15 | ₹880.60 | -1.58% |
Mon, Sep 16 2024 | ₹905.20 | ₹894.70 | |
Fri, Sep 13 2024 | ₹890.90 | ₹882.85 | -1.08% |
Thu, Sep 12 2024 | ₹878.65 | ₹892.50 | |
Wed, Sep 11 2024 | ₹845.00 | ₹875.45 |
Events
Corporate actions
Dividend • ₹1.1/share
Ex date 19 Sep 2022
Learn more